APA (7th ed.) Citation

Xie, Y., Li, Q., Ma, Y., Yang, Y., Jin, X., Yi, T., . . . Jin, X. (2025). RGS20 reduces glioma stemness and temozolomide resistance by intrinsically inhibiting the WNT/β-catenin signaling pathway. Scientific Reports, 15(1), 1. https://doi.org/10.1038/s41598-025-30291-z

Chicago Style (17th ed.) Citation

Xie, Yang, et al. "RGS20 Reduces Glioma Stemness and Temozolomide Resistance by Intrinsically Inhibiting the WNT/β-catenin Signaling Pathway." Scientific Reports 15, no. 1 (2025): 1. https://doi.org/10.1038/s41598-025-30291-z.

MLA (9th ed.) Citation

Xie, Yang, et al. "RGS20 Reduces Glioma Stemness and Temozolomide Resistance by Intrinsically Inhibiting the WNT/β-catenin Signaling Pathway." Scientific Reports, vol. 15, no. 1, 2025, p. 1, https://doi.org/10.1038/s41598-025-30291-z.